1) Clark MA, Fisher C, Judson I, et al. Soft-tissue sarcomas in adults. N Engl J Med 2005;353(7):701-11.
2) Giuliano AE, Eilber FR. The rationale for planned reoperation after unplanned total excision of soft-tissue sarcomas. J Clin Oncol 1985;3(10):1344-8.
3) 日本整形外科学会(監),日本整形外科学会診療ガイドライン委員会・軟部腫瘍診療ガイドライン策定委員会(編).軟部腫瘍ガイドライン2020(改訂第3版).東京:南江堂;2000.p.46-7.
4) Nakamura T, Kawai A, Sudo A. The incidence of unplanned excision in patients with soft tissue sarcoma:Reports from the Bone and Soft Tissue Tumor registry in Japan. J Orthop Sci 2022;27(2):468-72.
5) Pretell-Mazzini J, Barton MD Jr, Conway SA, et al. Unplanned excision of soft-tissue sarcomas:current concepts for management and prognosis. J Bone Joint Surg Am 2015;97(7):597-603.
6) Nakamura T, Kawai A, Hagi T, et al. A comparison of clinical outcomes between additional excision after unplanned and planned excisions in patients with soft-tissue sarcoma of the limb:a propensity matching cohort study. Bone Joint J 2021;103-B(12):1809-14.
7) Kwee RM, Kwee TC. Diagnostic performance of MRI in detecting residual soft tissue sarcoma after unplanned excision:systematic review and meta-analysis. Eur J Radiol 2021;145:110049. doi:10.1016/j.ejrad.2021.
8) Funovics PT, Vaselic S, Panotopoulos J, et al. The impact of re-excision of inadequately resected soft tissue sarcomas on surgical therapy, result and prognosis:a single institution experience with 682 patients. J Surg Oncol 2010;102(6):626-33.
9) Decanter G, Stoeckle E, Honore C, et al. Watch and wait approach for re-excision after unplanned yet macroscopically complete excision of extremity and superficial truncal soft tissue sarcoma is safe and dose not affect metastatic risk or amputation rate. Ann Surg Oncol 2019;26(11):3526-34.